Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Here, we study the intricate relationship between gut microbiota and host cometabolic phenotypes associated with dietary-induced impaired glucose homeostasis and nonalcoholic fatty liver disease (NAFLD) in a mouse strain (129S6) known to be susceptible to these disease traits, using plasma and urine metabotyping, achieved by (1)H NMR spectroscopy. Multivariate statistical modeling of the spectra shows that the genetic predisposition of the 129S6 mouse to impaired glucose homeostasis and NAFLD is associated with disruptions of choline metabolism, i.e., low circulating levels of plasma phosphatidylcholine and high urinary excretion of methylamines (dimethylamine, trimethylamine, and trimethylamine-N-oxide), coprocessed by symbiotic gut microbiota and mammalian enzyme systems. Conversion of choline into methylamines by microbiota in strain 129S6 on a high-fat diet reduces the bioavailability of choline and mimics the effect of choline-deficient diets, causing NAFLD. These data also indicate that gut microbiota may play an active role in the development of insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A causal role for the involvement of gut microbes is in part based on the fulfillment of one of Koch’s postulates - namely, the transmission of a disease related phenotype with transplantation of gut microbial organisms to a new host (Cho and Blaser, 2012; Cox et al., 2014; Dumas et al., 2006; Gregory et al., 2015; Koch, 1880; Sandhu and Chase, 1986).”
From Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis (2015) · cites this paper as Dumas et al., 2006
In the citing paper
“Interestingly, dysbiotic microbiota from mice fed a high-fat diet metabolize and convert dietary choline into methylamines, resulting in low circulating levels of plasma phosphatidylcholine60.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [60]
In the citing paper
“Serum and urinary concentrations of methylamines including TMAO were associated with the development of nonalcoholic fatty liver and impairment of glucose metabolism in high-fat-fed 129S6 mice (39).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [39]
In the citing paper
“It has been demonstrated that the gut microbiota can play a role in the development of metabolic abnormalities such as insulin resistance and nonalcoholic fatty liver disease76,77.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [77]
Citations
Cites
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Self-citationMetabonomics: a platform for studying drug toxicity and gene function
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd728 · Cited by 1,914
Self-citation
Research works printed but not linked: 2
- A. L. Buchman, M. D. Dubin, A. A. Moukarzel, D. J. Jenden, M. Roch, K. M. Rice, J. Gornbein, M. E. Ament Hepatology 22, 1399–1403 (1995).
- S. H. Zeisel, J. S. Wishnok, J. K. Blusztajn J. Pharmacol. Exp. Ther. 225, 320–324 (1983).
Cited by
Items 301–400 of 942
Metabolomic Applications to Decipher Gut Microbial Metabolic Influence in Health and Disease
Martin, F., Collino, S., Rezzi, S., & Kochhar, S. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00113 · Cited by 94
“…energy recovery from nutrients, generating digestible carbohydrates and short chain fatty acids (SCFAs) from otherwise non-digestible fibers, amino acids, and vitamins, to protection against infectious diseases (Cummings et al., 1987; Gilmore and Ferretti, 2003; Xu et al., 2003; Tannock, 2005).”
BackgroundNonalcoholic Fatty Liver Disease and the Gut Microbiome
Boursier, J., & Diehl, A. M. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.012 · Cited by 102
Metabolic alteration in obese diabetes rats upon treatment with Centella asiatica extract
Maulidiani, M., Abas, F., Khatib, A., Perumal, V., Suppaiah, V., Ismail, A., Hamid, M., Shaari, K., & Lajis, N. H. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.01.001 · Cited by 90
Gut microbiota and non-alcoholic fatty liver disease
Gkolfakis, P., Dimitriadis, G., & Τriantafyllou, Κ. (2015) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(15)60026-1 · Cited by 90
The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
Jennison, E., & Byrne, C. D. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0129 · Cited by 88
“Dysbiosis, and in particular an excess of the class Erysipelotrichia, has been associated with choline depletion in both animal and human studies.(25,62,63) Choline is metabolised by the gut microbiome to generate methylamines such as trimethylamine (TMA), which is converted in the liver to TMA-N-oxide (TMAO) by flavi…”
BackgroundAntimicrobials: Strategies for targeting obesity and metabolic health?
Murphy, E. F., Clarke, S. F., Marques, T. M., Hill, C., Stanton, C., Ross, R. P., O'Doherty, R. M., Shanahan, F., & Cotter, P. D. (2013) · Gut Microbes · doi:10.4161/gmic.22328 · Cited by 33
1H NMR metabolomics study of age profiling in children
Gu, H., Pan, Z., Xi, B., Hainline, B. E., Shanaiah, N., Asiago, V., Gowda, G. A. N., & Raftery, D. (2009) · NMR in Biomedicine · doi:10.1002/nbm.1395 · Cited by 87
Gut Microbiota: Association with NAFLD and Metabolic Disturbances
Lau, E., Carvalho, D., & Freitas, P. (2015) · BioMed Research International · doi:10.1155/2015/979515 · Cited by 86
“A high-fat diet in a mice model susceptible to impaired glucose homeostasis and NAFLD reduces the bioavailability of choline, mimicking the effect of choline-deficient diets [24].”
BackgroundInfluentialHe, Q., Tang, H., Ren, P., Kong, X., Wu, G., Yin, Y., & Wang, Y. (2011) · Journal of Proteome Research · doi:10.1021/pr200688u · Cited by 92
Oñate, F. P., Chamignon, C., Burz, S. D., Lapaque, N., Monnoye, M., Philippe, C., Bredel, M., Chêne, L., Farin, W., Paillarse, J.-M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512232 · Cited by 101
Yin, X., Peng, J., Zhao, L., Yu, Y., Zhang, X., Liu, P., Feng, Q., Hu, Y., & Pang, X. (2013) · Systematic and Applied Microbiology · doi:10.1016/j.syapm.2012.12.009 · Cited by 97
1H-NMR based metabonomic profiling of human esophageal cancer tissue
Wang, L., Chen, J., Chen, L., Deng, P., Bu, Q., Pu, X., Li, M., Lu, W., Xu, Y., Lin, H., et al. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-25 · Cited by 98
“The one is to form creatinine via DMG, and the other is converted to methylamine [54].”
Systems biology of the gut: the interplay of food, microbiota and host at the mucosal interface
dos Santos, V. A. P. M., Müller, M. M., & de Vos, W. M. (2010) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.08.003 · Cited by 91
Liu, C.-C., Wu, Y., Feng, G.-M., Gao, X., Zhou, Y., Hou, W.-J., Qin, X., Du, G., & Tian, J. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.05.005 · Cited by 93
Does Our Gut Microbiome Predict Cardiovascular Risk?: A Review of the Evidence From Metabolomics
Griffin, J. L., Wang, X., & Stanley, E. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.114.000219 · Cited by 92
A complex microworld in the gut: Gut microbiota and cardiovascular disease connectivity
Howitt, M. R., & Garrett, W. S. (2012) · Nature Medicine · doi:10.1038/nm.2895 · Cited by 78
Kussmann, M., & Van Bladeren, P. J. (2011) · Frontiers in Genetics · doi:10.3389/fgene.2011.00021 · Cited by 74
“This said, also other genetic modifications such as deletions (Smith et al., 2008), insertions (Payton et al., 2005) and copy number variants (CNVs; Need et al., 2009), are important and contribute to inter-individual variability in humans.”
Studying the Human Gut Microbiota in the Trans-Omics Era - Focus on Metagenomics and Metabonomics
Tuohy, K., Gougoulias, C., Shen, Q., Walton, G., Fava, F., & Ramnani, P. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168182 · Cited by 77
McClain, C. J., Barve, S., & Deaciuc, I. (2007) · Hepatology · doi:10.1002/hep.21788 · Cited by 88
Barton, R. H., Waterman, D., Bonner, F. W., Holmes, E. C., Clarke, R., Nicholson, J. K., & Lindon, J. C. (2009) · Molecular BioSystems · doi:10.1039/b907021d · Cited by 86
Self-citationMetaorganismal nutrient metabolism as a basis of cardiovascular disease
Brown, J. M., & Hazen, S. L. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000036 · Cited by 80
“Unautho metaorganismal pathways to diverse human diseases such as obesity [10–17], diabetes [18,19], hepatic steatosis [18–21], cancer [22,23], osteoporosis [24], and most recently CVD [25 && –27 && ,28].”
BackgroundSun, P., Jin, M., Ding, L., Lu, Y., Ma, H., Yuan, Y., & Zhou, Q. (2018) · Aquaculture · doi:10.1016/j.aquaculture.2018.02.018 · Cited by 87
Global Metabolic Responses of NMRI Mice to an Experimental Plasmodium berghei Infection
Li, J. V., Wang, Y., Saric, J., Nicholson, J. K., Dirnhofer, S., Singer, B. H., Tanner, M., Wittlin, S., Holmes, E. C., & Utzinger, J. (2008) · Journal of Proteome Research · doi:10.1021/pr800209d · Cited by 76
Self-citationWang, Q., Guo, M., Liu, Y., Xu, M., Shi, L., Li, X., Zhao, J., Zhang, H., Wang, G., & Chen, W. (2022) · Nutrients · doi:10.3390/nu14061222 · Cited by 102
“This microbe-dependent host metabolic response has been linked to a variety of diseases, including inherited metabolic disease, trimethylamine (fish malodor syndrome) [38], non-alcoholic fatty liver disease [39] and, most recently, respiratory and cardiovascular diseases [4].”
BackgroundMolecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases
Hyun, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179139 · Cited by 90
Tripolt, N. J., Leber, B., Triebl, A., Köfeler, H. C., Stadlbauer, V., & Sourij, H. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.005 · Cited by 88
Shyu, P. T., Ng, B. S. H., Ho, N., Chaw, R., Seah, Y. L., Marvalim, C., & Thibault, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-45020-6 · Cited by 94
Effects of Lifestyle Intervention on Plasma Trimethylamine N-Oxide in Obese Adults
Erickson, M. L., Malin, S. K., Wang, Z., Brown, J. M., Hazen, S. L., & Kirwan, J. P. (2019) · Nutrients · doi:10.3390/nu11010179 · Cited by 88
Gut Microbiota in Obesity and Metabolic Abnormalities: A Matter of Composition or Functionality?
Morán‐Ramos, S., López-Contreras, B. E., & Canizales‐Quinteros, S. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.11.003 · Cited by 96
Immunoglobulin A and liver diseases
Inamine, T., & Schnabl, B. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-017-1400-8 · Cited by 76
Bluemel, S., Williams, B., Knight, R., & Schnabl, B. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00245.2016 · Cited by 83
“High metabolic rates lead to choline deficiency in the host, which results in liver steatosis, because the liver cannot secrete very-low-density lipoprotein without the membrane component phosphatidylcholine (60, 200).”
BackgroundHe, X., Ji, G., Jia, W. P., & Li, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030300 · Cited by 89
“[95] performed metabotyping on plasma and urine samples of 129S6 mice with 1H-NMR spectroscopy and revealed that the genetic predisposition of 129S6 mice to impaired glucose tolerance and NAFLD was due to the gut microbial disruption of choline metabolism.”
MethodTian, J., Peng, G.-J., Gao, X., Zhou, Y., Xing, J., Qin, X., & Du, G. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.10.005 · Cited by 89
Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments
Scorletti, E., Calder, P. C., & Byrne, C. D. (2011) · Endocrine · doi:10.1007/s12020-011-9530-x · Cited by 80
“These effects could be potentially important for the pathogenesis of NAFLD and CVD as changes in gut microflora have been linked to fatty liver disease [46, 47] and CVD [48].”
BackgroundRubio‐Aliaga, I., de Roos, B., Sailer, M., McLoughlin, G. A., Boekschoten, M. V., van Erk, M., Bachmair, E., van Schothorst, E. M., Keijer, J., Coort, S. L., et al. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00179.2010 · Cited by 85
“In a mouse study of insulin resistance, the interplay of the host-gut microflora metabolism with respect to choline metabolism was also put forward as a potential contributor to the development of insulin resistance (11).”
BackgroundPezzino, S., Sofia, M., Faletra, G., Mazzone, C., Litrico, G., Greca, G. L., & Latteri, S. (2022) · Biology · doi:10.3390/biology11111622 · Cited by 88
Boulangé, C. L., Claus, S. P., Chou, C. J., Collino, S., Montoliu, I., Kochhar, S., Holmes, E. C., Rezzi, S., Nicholson, J. K., Dumas, M., et al. (2013) · Journal of Proteome Research · doi:10.1021/pr400051s · Cited by 72
Self-citationGut microbiota and nonalcoholic fatty liver disease
Machado, M. V., & Cortez-Pinto, H. (2012) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31457-7 · Cited by 154
Gut indigenous microbiota and epigenetics
Shenderov, B. A. (2012) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v23i0.17195 · Cited by 71
“A role of mammalian gut microbiota, as epigenetic modifying factor, in the pathogenesis of metabolic syndrome and associated diseases has been meant (12, 13).”
BackgroundProfiling techniques in nutrition and health research
Kussmann, M., Rezzi, S., & Daniel, H. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2008.02.003 · Cited by 80
Wei, Z., Li, F., & Pi, G. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.812596 · Cited by 86
Celarain, N., & Tomàs-Roig, J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1667-1 · Cited by 98
Cho, K., Moon, J. S., Kang, J., Jang, H. B., Lee, H., Park, S. I., Yu, K., & Cho, J. (2016) · Pediatric Obesity · doi:10.1111/ijpo.12114 · Cited by 84
The gut microbiome: scourge, sentinel or spectator?
Korecka, A., & Arulampalam, V. (2012) · Journal of Oral Microbiology · doi:10.3402/jom.v4i0.9367 · Cited by 77
“The gut microbiota has been attributed a role in the development of non-alcoholic fatty liver disease (NALFLD) (91, 92).”
BackgroundChikayama, E., Suto, M., Nishihara, T., Shinozaki, K., Hirayama, T., & Kikuchi, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003805 · Cited by 91
“Versatile sampling and robust H-NMR methods have improved disease diagnosis [9–12] and personalized healthcare [13–15], and have provided an important tool for the characterization of genetic variations [16].”
Bifari, F., Ruocco, C., Decimo, I., Fumagalli, G. F., Valerio, A., & Nisoli, E. (2017) · Genes & Nutrition · doi:10.1186/s12263-017-0582-2 · Cited by 73
“Lower butyrate levels are linked to low level inflammation, which in turn decreases insulin resistance [17, 21, 26].”
BackgroundThavarajah, D., Thavarajah, P., Abare, A., Basnagala, S., Lacher, C. P., Smith, P., & Combs, G. F. (2016) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2016.07.003 · Cited by 106
Migliozzi, M., Thavarajah, D., Thavarajah, P., & Smith, P. (2015) · Nutrients · doi:10.3390/nu7115471 · Cited by 98
“Recent discoveries suggest the intestinal microbiome and a prebiotic-rich, low-caloric diet can play important roles in combating obesity and related diseases [32,33].”
BackgroundOligosaccharides Might Contribute to the Antidiabetic Effect of Honey: A Review of the Literature
Erejuwa, O. O., Sulaiman, S. A., & Wahab, M. S. A. (2011) · Molecules · doi:10.3390/molecules17010248 · Cited by 78
“also provides evidence that implicates the role of gut microbiota in the development of insulin resistance [48].”
BackgroundDunn, W. B., Goodacre, R., Neyses, L., & Mamas, M. A. (2011) · Bioanalysis · doi:10.4155/bio.11.223 · Cited by 80
Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
Duarte, S. M. B., Stefano, J. T., & de Oliveira, C. P. M. S. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.04.006 · Cited by 92
Molecular Basis of C–N Bond Cleavage by the Glycyl Radical Enzyme Choline Trimethylamine-Lyase
Bodea, S., Funk, M. A., Balskus, E. P., & Drennan, C. L. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.07.020 · Cited by 73
“Although choline is an important nutrient for humans, conversion of choline to TMA by human gut microbiota and its further oxidation to trimethylamine Noxide by liver enzymes (Krueger and Williams, 2005) is implicated in diseases, including nonalcoholic fatty liver disease (Dumas et al., 2006), atherosclerosis (Tang e…”
BackgroundIntestinal microbiota in liver disease
Haque, T., & Barritt, A. S. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.02.004 · Cited by 81
Yu, D., Shu, X., Xiang, Y., Li, H., Yang, G., Gao, Y., Zheng, W., & Zhang, X. (2014) · Journal of Nutrition · doi:10.3945/jn.114.197533 · Cited by 84
“Gut bacteria can degrade dietary choline and thereby reduce choline bioavailability to the host (38) and may also trigger proinflammatory pathways via producing trimethylamines in the liver (39).”
BackgroundPublisher Correction: The gut–liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0031-8 · Cited by 70
Stols‐Gonçalves, D., Mak, A. L., Madsen, M. S. A., van der Vossen, E. W. J., Bruinstroop, E., Henneman, P., Mol, F., Scheithauer, T. P. M., Smits, L. P., Witjes, J. J., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2223330 · Cited by 76
“38,42 Interestingly, choline acts as a methyl donor, and some studies have shown that choline availability has a large impact on DNA methylation.”
BackgroundXie, G., Zhang, S., Zheng, X., & Jia, W. (2013) · ELECTROPHORESIS · doi:10.1002/elps.201300017 · Cited by 70
Development and validation of a UPLC/MS method for a nutritional metabolomic study of human plasma
Pereira, H., Martin, J., Joly, C., Sébédio, J., & Pujos‐Guillot, E. (2009) · Metabolomics · doi:10.1007/s11306-009-0188-9 · Cited by 81
Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?
Portincasa, P., Khalil, M., Graziani, A., Frühbeck, G., Baffy, G., Garruti, G., Ciaula, A. D., & Bonfrate, L. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.10.002 · Cited by 84
Maestri, M., Santopaolo, F., Pompili, M., Gasbarrini, A., & Ponziani, F. R. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1110536 · Cited by 79
“As the gut microbiota uses choline for the production of trimethylamine (TMA) (59), contributes to reduce choline bioavailability, mimicking the effects of a choline deficient diet (60).”
BackgroundFianchi, F., Liguori, A., Gasbarrini, A., Grieco, A., & Miele, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126485 · Cited by 83
“Indeed, it has been demonstrated that high-fat diets in mice are conducive to the development of an intestinal microbiota with the ability to convert dietary choline into methylamines, with consequently low circulating levels of plasma phosphatidylcholine and high urinary excretion of methylamines (dimethylamine, trim…”
BackgroundThe application of metabolomics in investigating anti-diabetic activity of medicinal plants
Hasanpour, M., Iranshahy, M., & Iranshahi, M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110263 · Cited by 76
Zhou, X.-L., Yan, B.-B., Xiao, Y., Zhou, Y.-M., & Liu, T.-Y. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.02.052 · Cited by 78
Implication of intestinal VDR deficiency in inflammatory bowel disease
Kim, J. H., Yamaori, S., Tanabe, T., Johnson, C. H., Krausz, K. W., Kato, S., & Gonzalez, F. J. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.09.020 · Cited by 68
Cui, H.-X., Hu, Y.-N., Li, J.-W., & Yuan, K. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8930374 · Cited by 74
Pathogenesis of type 1 diabetes: lessons from natural history studies of high‐risk individuals
Nokoff, N., & Rewers, M. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12021 · Cited by 93
Zhang, Z., Zhang, X., Wu, B., Yin, J., Yu, Y., & Yang, L. (2016) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2016.05.011 · Cited by 78
Jamali, R., Mofid, A., Vahedi, H., Farzaneh, R., & Dowlatshahi, S. (2013) · Hepatitis Monthly · doi:10.5812/hepatmon.14679 · Cited by 73
“It was suggested that gut microbiota might regulate IR (30).”
BackgroundProt, J.-M., Bunescu, A., Elena-Herrmann, B., Aninat, C., Snouber, L. C., Griscom, L., Razan, F., Bois, F. Y., Legallais, C., Brochot, C., et al. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.12.017 · Cited by 71
“…(Nicholson et al., 1999; 2002), is a powerful tool for characterizing variations in the concentration of such compounds in biofluids or organs in response to drug treatments (Clayton et al., 2006), but also to pathophysiology (Dumas et al., 2006) or genetic polymorphisms (Dumas et al., 2007).”
Self-citationMiyata, M., Yamakawa, H., Hamatsu, M., Kuribayashi, H., Takamatsu, Y., & Yamazoe, Y. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.171736 · Cited by 52
“They have been implicated in the pathogenesis of host disease such as nonalcoholic steatohepatitis, allergy, and inflammatory bowel disease (Noverr et al., 2004; Dumas et al., 2006; Frank et al., 2007; Alverdy and Chang, 2008).”
BackgroundGerges, S. H., Wahdan, S. A., Elsherbiny, D. A., & El‐Demerdash, E. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119220 · Cited by 84
Chromatin dynamics and histone modifications in intestinal microbiota-host crosstalk
Fellows, R., & Varga‐Weisz, P. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.12.005 · Cited by 80
“References for (A) [34,35,93e98], (B) [36,99], (C) [100,101], (D) [30,102], (E) [103e108], (F) [109e114], (G) [115,116], (H) [99,117e121], (I) [122e125], (J) [122,123,126e128], (K) [37,38,40e42,122e124,129,129e133], and (L) [28,29,134].”
Bifari, F., Manfrini, R., Dei Cas, M., Berra, C., Siano, M., Zuin, M., Paroni, R., & Folli, F. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.025 · Cited by 69
Li, F., Zhao, X., Tong, Q., Zhou, X., Chen, J., Xiong, W., Fang, J., Wang, W., & Shi, C. (2018) · Journal of Food Science · doi:10.1111/1750-3841.14128 · Cited by 69
Yang, X., Yin, F., Yang, Y., Lepp, D., Yu, H., Ruan, Z., Yang, C., Yin, Y., Hou, Y., Leeson, S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22565-6 · Cited by 77
What Have Metabolomics Approaches Taught Us About Type 2 Diabetes?
González-Franquesa, A., Burkart, A., ISGANAITIS, E. M., & Patti, M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0763-1 · Cited by 78
Yan, S., Shi, R., Li, L., Ma, S., Zhang, H., Jin, Y., Wang, J., Pan, J., Wang, Q., Jin, X., et al. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900521 · Cited by 87
Translating Metabolomics to Cardiovascular Biomarkers
Senn, T. N., Hazen, S. L., & Tang, W. H. W. (2012) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2012.06.004 · Cited by 78
The gastrointestinal microbiome: a malleable, third genome of mammals
Carroll, I. M., Threadgill, D. W., & Threadgill, D. S. (2009) · Mammalian Genome · doi:10.1007/s00335-009-9204-7 · Cited by 66
“For example, the GI microbiota can convert choline into methylamines, thus reducing the availability of choline in mice maintained on a high-fat diet (Dumas et al. 2006).”
BackgroundNovel omics technologies in nutrition research
Zhang, X., Yap, Y., Wei, D., Chen, G., & Chen, F. (2007) · Biotechnology Advances · doi:10.1016/j.biotechadv.2007.11.002 · Cited by 80
Microbiome to Brain: Unravelling the Multidirectional Axes of Communication
Aidy, S. E., Stilling, R. M., Dinan, T. G., & Cryan, J. F. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-20215-0_15 · Cited by 69
“TRIMETHYLAMINE (TMA) is the product of microbiota-dependent choline (essential dietary nutrient) metabolism (Dumas et al. 2006 ).”
BackgroundMetagenomics of the Human Body
Nelson, K. E. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7089-3 · Cited by 121
Ilyas, A., Wijayasinghe, Y. S., Khan, I., Samaloty, N. M. E., Adnan, M., Dar, T. A., Poddar, N. K., Singh, L. R., Sharma, H., & Khan, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.964624 · Cited by 76
“An early study identified that gut microbiota-derived methylamines or decreased choline bioavailability perform an appreciable role in the progression of insulin resistance and non-alcoholic fatty liver disease (NAFLD) in high-fat diet-fed mice (Dumas et al., 2006).”
BackgroundGut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?
Jiang, L., & Schnabl, B. (2020) · Physiology · doi:10.1152/physiol.00005.2020 · Cited by 77
Blasco‐Baqué, V., Coupé, B., Fabre, A., Handgraaf, S., Gourdy, P., Arnal, J., Courtney, M., Schuster, C., Guardiola, B., Tercé, F., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4209-3 · Cited by 77
“Moreover, the alteration of gut microbiota, termed dysbiosis, is an additional causal factor in the development of hepatic steatosis [16], a condition that involves the accumulation of hepatic triacylglycerols, which is a common feature of metabolic disease [17].”
BackgroundWang, X., Su, M., Qiu, Y., Ni, Y., Zhao, T., Zhou, M., Zhao, A., Yang, S., Zhao, L., & Jia, W. P. (2007) · Journal of Proteome Research · doi:10.1021/pr070051w · Cited by 67
The Gut Microbiota and their Metabolites: Potential Implications for the Host Epigenome
Mischke, M., & Plösch, T. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-31248-4_3 · Cited by 94
The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target
Kessoku, T., Kobayashi, T., Tanaka, K., Yamamoto, A., Takahashi, K., Iwaki, M., Ozaki, A., Kasai, Y., Nogami, A., Honda, Y., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158161 · Cited by 86
Pancreatic and mucosal enzymes in choline phospholipid digestion
Nilsson, Å., & Duan, R. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00320.2018 · Cited by 75
Gut Microbiota and Host Reaction in Liver Diseases
Fukui, H. (2015) · Microorganisms · doi:10.3390/microorganisms3040759 · Cited by 65
“High-fat diet leads to the formation of intestinal microbiota that convert dietary choline into methylamines [109].”
BackgroundAgus, A., Massier, S., Darfeuille–Michaud, A., Billard, E., & Barnich, N. (2014) · BioMed Research International · doi:10.1155/2014/567929 · Cited by 94
“Thus, it is important to understand the involvement of microbiota in the etiology of such diseases by characterizing species that compose a “healthy” microbiota [3–8].”
BackgroundSrikanth, C. V., & McCormick, B. A. (2008) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2008/626827 · Cited by 62
“More recent studies suggest that the commensal microbiota play an important role in the development of numerous conditions, including obesity [4, 5], diabetes [6], nonalcoholic fatty liver disease [7], inflammatory bowel disease [8], and perhaps cancer [9].”
BackgroundMicrobiome as an immune regulator in health, disease, and therapeutics
Juarez, V. M., Montalbine, A. N., & Singh, A. K. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114400 · Cited by 79
The PPAR–microbiota–metabolic organ trilogy to fine‐tune physiology
Oh, H. Y. P., Visvalingam, V., & Wahli, W. (2019) · The FASEB Journal · doi:10.1096/fj.201802681rr · Cited by 85
“Butyrate also enhances the expression and activation of PPAR-b/d via AMPK and PGC-1a (9).”
BackgroundInfluentialPatel, D. P., Krausz, K. W., Xie, C., Beyoğlu, D., Gonzalez, F. J., & Idle, J. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177953 · Cited by 73
“Moreover, the gut microbiota have significant roles to play in HFD-induced obesity in terms of energy harvest [3,23], insulin resistance [24], and modulations to host metabolisms [25,26].”
BackgroundGao, X., Xu, J., Jiang, C., Zhang, Y., Xue, Y., Li, Z., Wang, J., Xue, C., & Wang, Y. (2015) · Food & Function · doi:10.1039/c5fo00007f · Cited by 60
Kigerl, K. A., Zane, K., Adams, K., Sullivan, M. B., & Popovich, P. G. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113085 · Cited by 72
Won, E.-Y., Yoon, M., Kim, S. W., Jung, Y., Bae, H.-W., Lee, D., Park, S. G., Lee, C., Hwang, G., & Chi, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075998 · Cited by 68
“An inverse relationship of microbiome-originated metabolites might be due to variations in the mouse strain utilized [60].”
BackgroundMetabolome 2.0: quantitative genetics and network biology of metabolic phenotypes
Dumas, M. (2012) · Molecular BioSystems · doi:10.1039/c2mb25167a · Cited by 71
Self-citationHuo, X., Li, J., Cao, Y.-F., Li, S.-N., Shao, P., Leng, J., Li, W., Liu, J., Yang, K., Ma, R. C. W., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00710 · Cited by 65
Metadata
- Authors
- Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., Mitchell, S. C., Holmes, E., McCarthy, M. I., Scott, J., Gauguier, D., & Nicholson, J. K.
- Affiliations
- Imperial College London (GB)
- *Department of Biological Chemistry and
- Centre for Human Genetics (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-08-15
- Volume
- 103
- Issue
- 33
- Pages
- 12511-12516
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1567909
- OpenAlex
- W2139464173
- Cited by
- 1,042
- References
- 0
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 29 · 2023: 26 · 2022: 43 · 2021: 57 · 2020: 52 · 2019: 80 · 2018: 70 · 2017: 67 · 2016: 86 · 2015: 72 · 2014: 63 · 2013: 80 · 2012: 62
- FWCI
- 17.42
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (057733, 066786)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- gut microbiota, non-alcoholic fatty liver disease, insulin resistance, choline metabolism, phosphatidylcholine, trimethylamine N-oxide, methylamine, high-fat diet, impaired glucose homeostasis, metabotyping, host-microbe interactions, choline deficiency
- MeSH terms
- Animals, Body Weight, Dietary Fats, Fatty Liver, Glucose, Homeostasis, Insulin, Insulin Resistance, Lipids, Liver, Male, Methylamines, Mice, Inbred BALB C, Phenotype, Multivariate Analysis, Nuclear Magnetic Resonance, Biomolecular, Gastrointestinal Tract, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.